Skip to content

Clinical trials

Observational Prostatic Neoplasms trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Observational Country / region: Finland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20153
20162
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Helsinki University Central Hospital2
Tampere University Hospital2
Turku University Hospital2
Bayer1
Ferring Pharmaceuticals1
GlaxoSmithKline1
National Human Genome Research Institute (NHGRI)1
Pfizer1
Steba Biotech S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms12
Prostatic Hyperplasia2
Adenocarcinoma1
Brain Neoplasms1
Enterobacteriaceae Infections1
Hematoma, Subdural, Chronic1
Hip Fractures1
Lung Neoplasms1
Neoplasm Metastasis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.